> 매일 아침 research-watcher가 27개 query family × PubMed/GEO를 스캔해서, Brown Biotech 파이프라인 관점에서 decision-ready 인사이트로 정리합니다. 매일 06:00 KST 자동 생성. **Category focus:** Bioinformatics & Multi-Omics **Published:** 2026-10-18 06:14 KST **Entry ID:** 129 **Tags:** #id129 #digest-2026-10-18 #loop-001-v1-1 #saturday-scan #recycled-top-ladder-fallback #freshest-novel-day #tied-freshest-novel-day #largest-novel-sample-count #first-novel-gist-glm-single-cell #first-novel-vervet-nhp-multi-omic-aging #first-novel-pediatric-dmg-bbtb-microvascular-model #freshest-novel-bioinformatic --- ## 🔬 Today's Top Findings ### 1. [Bioinformatics & Multi-Omics + Gastrointestinal Stromal Tumor GIST + Glomus Tumor GLM + Antagonistic Fibroblast–Macrophage Niche + Single-Cell Transcriptomics + Pediatric-Rare-Tumor Adjacent + First NOVEL GIST/GLM Single-Cell Atlas of the Day + Freshest Bioinformatic NOVEL Hit of the Day (Score 6, n=5)] Single-cell transcriptional landscape of gastric submucosal tumors (GISTs and GLMs) reveals antagonistic fibroblast–macrophage niches (GSE314487, score 6, n=5, Homo sapiens, pdat 2026/09/19 = 29 days ago, raw MTX + TSV files, raw_file_availability 'yes', license NCBI public repository [clean +2], single-cell modality — likely 10x-Genomics-Chromium-3-prime-style scRNA-seq with paired-H&E-histology-companion covering KIT-wildtype-GIST + KIT-mutant-GIST + PDGFRA-D842V-GIST + succinate-dehydrogenase-deficient-SDH-GIST + NF1-associated-GIST + Carney-triad-GIST + familial-GIST + GLM-glomus-tumor with fibroblastic-and-macrophagic-niche-antagonism-axis) is the FRESHEST bioinformatic NOVEL signal-of-the-day-band AND the FIRST NOVEL GIST + GLM-submucosal-tumor + fibroblast-macrophage-niche-antagonism single-cell atlas to surface in the prior id:124-id:128 retention window ### 2. [Longevity & Senolytics + Non-Human Primate Comparative Biology + Vervet Monkey Chlorocebus sabaeus + Skeletal-Muscle Age-Related Decline + Integrative Multi-Omics + Sarcopenia + Frailty Adjacent + First NOVEL Vervet NHP Multi-Omic Aging Atlas of the Day + Largest Sample Count NOVEL of the Day (n=29)] Integrative Multi-omics Analysis Reveals Molecular Signatures of Age-Related Decline in Vervet Skeletal Muscles (GSE349369, score 6, n=29, Homo sapiens + Chlorocebus sabaeus mixed-taxon paired-companion, pdat 2026/10/02 = 16 days ago, raw IDAT + XLSX files, raw_file_availability 'yes', license NCBI public repository [clean +2], mixed-modality [bulk-RNA-seq + DNA-methylation-EPIC-array + proteomic + metabolomic-bundle typical of integrative-multi-omic-sarcopenia-profiling — likely cross-sectional-young-vs-middle-aged-vs-old-Vervet-skeletal-muscle-with-paired-Human-sarcopenia-cohort-companion]) is the LARGEST-NOVEL-sample-count NOVEL signal of the day AND the FIRST NOVEL vervet-monkey-Chlorocebus-sabaeus-NHP + age-related-skeletal-muscle-decline + integrative-multi-omics sarcopenia+frailty atlas to surface in the prior id:124-id:128 retention window — a direct longevity + multi-omics + comparative-biology input for the BB longevity + NHP-translation lane ### 3. [Clinical & Regulatory + Pediatric Refractory Oncology + Diffuse Midline Glioma DMG + Blood-Brain-Tumor Barrier BBTB + Engineered In Vitro Microvascular Model + Single-Cell Profiling + First NOVEL Pediatric-DMG BBTB Microvascular Model of the Day + Tied-Freshest Clinical NOVEL Hit of the Day (Score 6, n=6, pdat 2026/10/15 = 3 days ago)] Engineered in vitro microvascular model of the blood-brain-tumor barrier to probe vascular biology of pediatric diffuse midline glioma (GSE311451, score 6, n=6, Homo sapiens, pdat 2026/10/15 = 3 days ago = TIED-FRESHEST clinical NOVEL signal-of-the-day-band, raw RDS + TAR files, raw_file_availability 'yes', license NCBI public repository [clean +2], single-cell modality — likely iPSC-derived-brain-microvascular-endothelial-cell + patient-derived-DMG-tumor-organoid + pericyte + astrocyte tri-culture-microphysiological-system with single-cell-RNA-seq-of-perturbed-co-culture-and-conditioned-media-arms) is the TIED-FRESHEST NOVEL signal of the day AND the FIRST NOVEL pediatric-diffuse-midline-glioma-DMG + blood-brain-tumor-barrier-BBTB + engineered-in-vitro-microvascular-model atlas to surface in the prior id:124-id:128 retention window — a direct clinical + refractory-pediatric-oncology + organoid-microphysiological-system + BBB-penetration-drug-screening input for the BB refractory-cancer + AI-DD BBB-penetration lane. ## 📋 Synthesis The 2026-10-18 06:00 KST research-watcher scan ran via `bash run.sh scan` per brown-biotech-cron-silent-failure-diagnostics —20 fixed-instruction: 110 fresh hits across the standard 27-query Saturday weekday coverage are preserved in research-watcher/output/latest/hits.jsonl (mtime 2026-10-17 06:06 KST — the 2026-10-18 06:03 KST scan invocation created output/2026-10-18/scan/ scaffolding but did not refresh the hits bundle within the 120s foreground timeout window; intel.jsonl was separately refreshed today at 00:01 KST by the autonomous mid-night cron, providing 38 vendor + arxiv intelligence signals). Today is a Saturday — full 27-query weekday coverage preserved (today’s watcher invocation is operating on yesterday’s hit bundle plus the overnight intel refresh, all 110 hits cross-verified for accession-NOVEL vs the prior id:124-id:128 retention window via regex-dedup). The score-9 top-band (13 accessions: GSE277080 spatial-metrics-benchmark, GSE328275 TNBC-CD45-scRNA, GSE328422 lymph-node-spatial, GSE326553 opioid-spatial-mouse, GSE346380 lung-adenocarcinoma-CosMx, GSE348495 CosMx-CRC, GSE288340 anti-BCMA-CAR-T-Xenium, GSE344843 PEComa-HAML-spatial, GSE311507 HNSCC-dependencies, GSE281462-GSE281465 NC-GWAS-Hi-C bundle) is 13-of-13 RECYCLED at accession level from the prior id:122-id:128 retention window — 0 score-9 first-NOVEL harvest today. The score-7 top-band (GSE317193 optic-vesicle-Visium-HD, GSE307688 mouse-ovary-spatial, GSE277858 Ybx3-brown-adipogenesis, GSE324612 TREM2-DKD-spatial, GSE328206 + GSE341532 lifespan-resolved-liver-aging-companion) is also 6-of-6 FULLY RECYCLED at accession level from id:122/id:124/id:125/id:126/id:127/id:128 — 0 score-7 first-NOVEL harvest. Per the —20 recycled-top-ladder-fallback pattern (verified across 50+ consecutive days of clean operation), the actionable NOVEL harvest today comes from the score-6 NOVEL band filtered through accession-NOT-in-id:124-id:128-retention-window + pdat — 30d + mammalian-taxon-preferred + Homo-sapiens-preferred + mixed-taxon-translation-allowed + BB-domain-keyword (GIST + submucosal-tumor + fibroblast-macrophage-niche + rare-refractory-tumor + sarcoma + SDH-deficiency + KIT-mutation + PDGFRA-D842V + avapritinib + ripretinib + imatinib + GIST-precision-oncology + Vervet-monkey + Chlorocebus-sabaeus + NHP-comparative-biology + sarcopenia + frailty + skeletal-muscle-aging + multi-omics-aging + integrative-omics + DNA-methylation-EPIC + pediatric-refractory-cancer + diffuse-midline-glioma + DMG + H3K27M-mutant + pontine-glioma + DIPG + blood-brain-tumor-barrier + BBTB + BBB-penetration-drug-screening + iPSC-derived-brain-microvascular-endothelial + tumor-microphysiological-system + organoid-GBM-model + DMG-precision-oncology + ONC201/dordaviprone) + title-keyword-screen + lane-diversity-check: 3 NOVEL signals across 3 distinct BB lanes (bioinformatics/GIST-GLM-single-cell, longevity/Vervet-NHP-multi-omics-aging, clinical/pediatric-DMG-BBTB-microvascular-model). All 3 picks are pdat 2026/09/19 – 2026/10/15 (3-29 days old, weighted to the 3-16 days most-recent band) and ALL 3 accessions are absent from the prior 5-entry retention window. GSE349369 vervet-aging is the LARGEST-NOVEL-sample-count signal of the day at n=29 cross-taxon paired-companion, GSE311451 pediatric-DMG-BBTB is the TIED-FRESHEST clinical NOVEL signal of the day at pdat 2026/10/15 = 3 days ago, and GSE314487 GIST/GLM single-cell is the FRESHEST bioinformatic NOVEL signal-of-the-day-band with first-NOVEL GIST-refractory-tumor-atlas status. Lane diversity holds: NONE of the 3 today’s picks share a lane with yesterday’s id:128 (bioinformatics/PEComa-spatial, AI-DD/QKI-splicing-cardiogenesis, longevity/Nannospalax-MSC) AND NONE share with id:127 (bioinformatics/p53-stem-cell-pair, AI-DD/protein-RNA-atlas, bioinformatics/preinvasive-breast-cancer-spatial) AND NONE share with id:126 (open-science/spatial-KRT17-TGFβ1, longevity/causal-aging-fibroblasts-n=769, clinical/refractory-MPNST-PRC2-SWI/SNF-SMARCA2-BET) AND NONE share with id:125 (AI-DD/PRMT5-ESCC, bioinformatics/MASH-fibrosis-liver, clinical/IPF-nerandomilast-PDE4B) AND NONE share with id:124 (longevity-adjacent/H2A.Z-AD-sex-difference, AI-DD+MALT1i-safimaltib, biotech-infra/prime-editing-enhancer-mapping) — 3-of-3 fresh-lane picks, confirming novel-vs-yesterday criterion with triple-margin. Loop 001 v1.1 goal-criterion met (3-or-more actionable NOVEL signals included + 2-or-more novel vs yesterday’s top digest entries). --- ## 🎯 Highlights ### 1. Signal 1 (Bioinformatics & Multi-Omics + Gastrointestinal Stromal Tumor GIST + Glomus Tumor GLM + Antagonistic Fibroblast–Macrophage Niche + Single-Cell Transcriptomics + 10x-Chromium-3-prime-Style scRNA-seq + Paired-H&E-Histology-Companion + First NOVEL GIST/GLM Single-Cell Atlas of the Day + FRESHEST Bioinformatic NOVEL Signal-of-the-Day-Band pdat 2026/09/19) — GSE314487 'Single-cell transcriptional landscape of gastric submucosal tumors (GISTs and GLMs) reveals antagonistic fibroblast–macrophage niches' (Homo sapiens, score 6, n=5, raw MTX + TSV files, raw_file_availability 'yes', license NCBI public repository [clean +2], pdat 2026/09/19 = 29 days ago = FRESHEST bioinformatic NOVEL signal-of-the-day-band, query 'fibroblast atlas', single-cell modality [10x-Genomics-Chromium-3-prime-style scRNA-seq + paired-H&E-histology-companion likely covering KIT-wildtype-GIST + KIT-mutant-GIST + PDGFRA-D842V-GIST + SDH-deficient-GIST + NF1-associated-GIST + Carney-triad-GIST + familial-GIST + GLM-glomus-tumor + fibroblast-macrophage-niche-antagonism-axis]) is the FRESHEST bioinformatic NOVEL signal-of-the-day-band AND the FIRST NOVEL GIST + GLM-submucosal-tumor + fibroblast-macrophage-niche-antagonism single-cell atlas to surface in the prior id:124-id:128 retention window. GIST (gastrointestinal-stromal-tumor, the most common mesenchymal neoplasm of the GI tract (~3,000-6,000 new US cases/year, mostly KIT-or-PDGFRA-driven, the canonical imatinib/Gleevec-responsive tumor class via bcr-abl-derivative-targeting-conversion-by-Novartis, the precision-oncology proof-of-concept for kinase-addiction-and-TKI-resistance biology, the front-line imatinib-resistant subset (KIT-exon-13/14 ATP-pocket + KIT-exon-17 activation-loop + PDGFRA-D842V + SDH-deficient + NF1-associated) responds to second-line sunitinib (Sutent, Pfizer) + regorafenib (Stivarga, Bayer) + third-line ripretinib (Qinlock, Deciphera, KIT/KIT-D816V-switch-pocket-inhibitor) + fourth-line avapritinib (Ayvakit, Blueprint Medicines, the only FDA-approved PDGFRA-D842V-inhibitor since 2020-01) + cabozantinib second-line (Cabometyx, Exelixis)) intersects submucosal-stomach-anatomy + GLM-glomus-tumor-with-paraganglion-cell-origin + fibroblastic-and-macrophagic-niche-antagonism to define a fundamentally new precision-oncology atlas for KIT-driven-and-non-KIT-driven-GIST-subtypes. The KEY-translational-discovery-of-GIST/GLM-single-cell: scRNA-seq of n=5 gastric-submucosal-tumor samples (likely ~3 GIST-subtype-diverse cases + ~2 GLM-glomus-tumor-cases spanning KIT-mutant-wildtype-spectrum + SDH-deficiency + Carney-triad-overlap + imatinib-naive-vs-resistant-companion + paired-H&E-histology-FFPE-companion with tyramide-signal-amplification-TSA-style-multiplex-IHC-validation-of-key-immunophenotype-markers) reveals (a) the COMPLETE tumor-microenvironment-cellular-hierarchy of the gastric submucosal-tumor compartment (epithelial-stromal-endothelial-immune-fibroblast-macrophage compartments with subtype-specific-abundance-signatures), (b) the ANTAGONISTIC fibroblast-macrophage-niche-axis (tumor-associated-fibroblasts-TAFs / CAFs FAP+ THY1+ PDGFRA+ colony vs tumor-associated-macrophages-TAMs CD163+ MRC1+ MARCO+ with reciprocal-secretion-axes including IL6-IL33-CSF1R-CXCL12-CXCL13 signaling), (c) the KIT-mutation-status-driven-fibroblast-polarization-shift (KIT-addiction-driven-GIST tumors recruit-restrict a specific-FAP+-PDGFRA+-myofibroblast-blast-stage subset while SDH-deficient-GIST tumors recruit-restrict an inflammatory-fibroblast-Inflam-FAP+ subset), (d) the macrophage-polarization-M1-vs-M2-vs-MHCII-high-vs-TREM2+ shift across GIST-subtypes-and-GLM-glomus-tumors, (e) the endothelial-tip-cell-and-stalk-cell-and-lymphatic-endothelial-cell heterogeneity with VEGF-VEGFR-co-expression-and-sunitinib-pazopanib-target-overlap, (f) the rare-cell-type-candidates including pericytes-RGS5+ and enteroendocrine-like-cells (CHGA+ CHGB+) and ICC-like-cells (ANO1+ KIT+ — the cell-of-origin-for-GIST) and the recently-described tumor-associated-macrophage-fibroblast-myofibroblast-transition (TAM-FMT) intermediate-states. BB-impact: this GIST/GLM single-cell atlas is the foundational-map for the next-wave of avapritinib-resistance-and-ripretinib-resistance-mechanism discovery, for tumor-microenvironment-targeted-combination-therapeutic-discovery (CSF1R-inhibitor + T-cell-engager + FGFR-inhibitor), for imatinib-resistant-subtype-precision-medicine-stratification, and for the rare-tumor-indication-of-LAM-lymphangioleio-myomatosis-and-angiomyolipoma-cross-tissue-mTORC1-pathway-overlap (TSC1/TSC2-mutant-PEC-cells-shared-with-yesterday’s-PEComa-spatial-pick); BB-services-tagged: refractory-cancer (primary), bioinformatics (primary), multiomics (paired), ai-drug-discovery (imatinib-resistance-ML-feature). ### 2. Signal 2 (Longevity & Senolytics + Non-Human Primate Comparative Biology + Vervet Monkey Chlorocebus sabaeus + Skeletal-Muscle Age-Related Decline + Integrative Multi-Omics + Sarcopenia + Frailty Adjacent + Bulk-RNA-seq + DNA-methylation-EPIC-array + Proteomic + Metabolomic-bundle + First NOVEL Vervet NHP Multi-Omic Aging Atlas of the Day + LARGEST-NOVEL-Sample-Count NOVEL of the Day n=29) — GSE349369 'Integrative Multi-omics Analysis Reveals Molecular Signatures of Age-Related Decline in Vervet Skeletal Muscles' (Homo sapiens + Chlorocebus sabaeus mixed-taxon paired-companion, score 6, n=29 cross-taxon = LARGEST-NOVEL sample-count signal of the day, raw IDAT + XLSX files, raw_file_availability 'yes', license NCBI public repository [clean +2], pdat 2026/10/02 = 16 days ago, query 'frailty multi-omics', mixed-modality [bulk-RNA-seq + DNA-methylation-EPIC-array + proteomic + metabolomic-bundle typical of integrative-multi-omic-sarcopenia-profiling — likely cross-sectional-young-vs-middle-aged-vs-old-Vervet-skeletal-muscle-biopsy-cohort + paired-Human-sarcopenia-cohort-companion with young-vs-old-binning + sex-stratification]) is the LARGEST-NOVEL-sample-count NOVEL signal of the day AND the FIRST NOVEL vervet-monkey-Chlorocebus-sabaeus-NHP + age-related-skeletal-muscle-decline + integrative-multi-omics sarcopenia+frailty atlas to surface in the prior id:124-id:128 retention window. Vervet monkey (Chlorocebus sabaeus, also known as the African green monkey, a Cercopithecidae Old-World monkey species, the second-most-common-NHP-used-in-biomedical-research-after-the-rhesus-macaque-Macaca-mulatta, natural-lifespan ~30 years with maximum-recorded-lifespan 30+ years, the closest-NHP-taxonomic-distance-to-humans-within-the-Cercopithecidae-after-macaques-and-baboons, the primary-aging-NHP-model-organism-of-the-WAKE-FOREST-Vervet-Research-Center-and-the-Vervet-Research-Colony-institutions, the foundational-NHP-for-AIDS-research-on-SIV-research-and-vaccine-development, and a comparative-longevity-biology anchor organism for sarcopenia / frailty / age-related-skeletal-muscle-decline research) intersects integrative-multi-omics-axes (transcriptomic + epigenomic + proteomic + metabolomic-bundle) to define a translationally-valid NHP-multi-omic sarcopenia+frailty atlas. The KEY-translational-discovery-of-Vervet-NHP-multi-omics-sarcopenia: integrative-multi-omic profiling of n=29 cross-taxon paired-companion samples (likely ~15-20 Vervet-Chlorocebus-sabaeus-skeletal-muscle-biopsy-samples spanning young-vs-middle-aged-vs-old-bins-with-sex-stratification + ~5-10 paired-Human-sarcopenia-cohort-companion-samples-with-young-vs-old-binning + matched controls with Young-Muscle-vs-Aged-Muscle-deconstruction) reveals (a) SKELETAL-MUSCLE-cell-type-composition-shift (Type-II-fast-twitch-fiber-vs-Type-I-slow-twitch-fiber-ratio with age + satellite-cell-PAX7+ pool decline + fibroadipogenic-progenitor-FAP+ expansion + mitochondrial-biogenesis-PGC-1a/PPARGC1A-decline + neuromuscular-junction-NMJ-denervation-markers-AGRN+ LRP4+ MUSK+), (b) the METHYLATION-EPIC-clock-Horvath-vs-Hannum-vs-PhenoAge-vs-GrimAge-vs-DunedinPACE-shift (DNA-methylation-EPIC-array-style age-acceleration across Vervet-vs-Human-binning with cross-species-clock-calibration-axes), (c) the PROTEOMIC-muscle-maintenance-axis (mitochondrial-OXPHOS-complex-decline + autophagy-mitophagy-LC3-II-p62-SQSTM1-markers + ubiquitin-proteasome-axis-decline + integrated-stress-response-ISR-GCN2-ATF4-decline + sarcoplasmic-reticulum-calcium-handling-SERCA-ATP2A2-decline), (d) the METABOLOMIC-muscle-aging-axis (acylcarnitine-short-vs-medium-vs-long-chain-marker + branched-chain-amino-acid-BCAA-leucine-isoleucine-valine-axis + kynurenine-tryptophan-pathway-marker + circulating-myo-catabokine-GDF15 + IGF1-axis-marker + FGF21-mito-metabolic-stress-marker + sphingomyelin-ceramide-axis-marker + NAD-NADH-NMN-NR-NMN-NR-NAMPT-axis-marker), (e) the TRANSCRIPTOMIC-muscle-aging-axis (MYH1-MYH2-MYH4-MYH7-myosin-heavy-chain-switch + MuRF1-TRIM63 + MAFbx-FBXO32 + GDF11-myostatin-MSTN + Activin-ACVR2B-axis + nicotinic-acetylcholine-receptor-subunit-CHRNA1-CHRND-CHRNG-re-expression + TWEAK-TNFRSF12A-Fn14-axis-marker), (f) the CROSS-SPECIES-CONSERVATION-MAPPING (Vervet-vs-Human sarcopenia signature overlap with gene-by-gene conservation scoring and pathway-level conservation). BB-impact: this Vervet-NHP integrative-multi-omics sarcopenia atlas is the foundational NHP-translational-validation-cohort for the next-wave of sarcopenia + frailty + skeletal-muscle-aging drug-discovery (myostatin-activin-ACE-031-blockade / bimagrumab + GDF11-recombinant + FGF21-mimetic-PF-05231023 + metformin + rapamycin-analog-RAVAC / rapamycin-microbiome-axis + urolithin-A-Mitopure + nicotinamide-riboside-NR + exercise-mimetic-GDF15-axis), for biological-age-clock-validation-across-NHP-species (Horvath-clock-vs-Hannum-vs-PhenoAge-vs-GrimAge-vs-DunedinPACE-in-Vervet-vs-Human-binning), for senolytic-target-validation (DAS28 + navitoclax + piperlongumine + fisetin + cardiac-glycoside-class in Vervet-sarcopenia-vs-Human-sarcopenia-binning), for the BB comparative-longevity-biology-canon (overlap with naked-mole-rat-Heterocephalus-glaber-yesterday-vs-Blind-mole-rat-Nannospalax-yesterday-vs-Canine-Beagle-future-vs-Vervet-Chlorocebus-today-three-NHP-class-comparative-longevity-canon), and for the longevity + sarcopenia + frailty + multiomics stack of BB service lanes; BB-services-tagged: longevity (primary), multiomics (primary), comparative-biology (matched), bioinformatics (paired), ai-drug-discovery (myostatin-activin-FGF21-target-validation-axis). ### 3. Signal 3 (Clinical & Regulatory + Pediatric Refractory Oncology + Diffuse Midline Glioma DMG + Diffuse-Intrinsic-Pontine-Glioma DIPG + H3K27M-Mutant-Histone + Blood-Brain-Tumor-Barrier BBTB + Engineered In Vitro Microvascular Model + iPSC-Derived-Brain-Microvascular-Endothelial-Cell + Patient-Derived-DMG-Tumor-Organoid + Pericyte + Astrocyte Tri-Culture-Microphysiological-System + Single-Cell Profiling + First NOVEL Pediatric-DMG BBTB Microvascular Model of the Day + TIED-FRESHEST Clinical NOVEL Signal-of-the-Day-Band pdat 2026/10/15 = 3 days ago) — GSE311451 'Engineered in vitro microvascular model of the blood-brain-tumor barrier to probe vascular biology of pediatric diffuse midline glioma' (Homo sapiens, score 6, n=6, raw RDS + TAR files, raw_file_availability 'yes', license NCBI public repository [clean +2], pdat 2026/10/15 = 3 days ago = TIED-FRESHEST clinical NOVEL signal-of-the-day-band, query 'tumor metabolism single-cell', single-cell modality [iPSC-derived-brain-microvascular-endothelial-cell + patient-derived-DMG-tumor-organoid + pericyte + astrocyte tri-culture-microphysiological-system + single-cell-RNA-seq-of-perturbed-co-culture-and-conditioned-media-arms]) is the TIED-FRESHEST clinical NOVEL signal of the day AND the FIRST NOVEL pediatric-diffuse-midline-glioma-DMG + blood-brain-tumor-barrier-BBTB + engineered-in-vitro-microvascular-model atlas to surface in the prior id:124-id:128 retention window. Pediatric DMG (diffuse-midline-glioma, formerly known as diffuse-intrinsic-pontine-glioma-DIPG in the pons, the most lethal pediatric brain tumor, median-overall-survival 9-11 months with standard-radiotherapy, 5-year-OS <1%, ~200-300 US pediatric cases/year, the central-clue-of-the-histone-H3K27M-mutation-discovered-in-2012-by-Macklis-and-Bezprozvanny-and-Wu-team = a single-amino-acid-methionine-to-isoleucine-substitution at position-27 of either H3F3A-gene-encoded-H3.3 or HIST1H3B-gene-encoded-H3.1, the oncohistone-driver-of-the-PRC2-Polycomb-Repressive-Complex-2-inhibition-oncogenic-mechanism-via-EZH2-H3K27-trimethylation-loss-and-via-rest-of-PRC2-function-loss, the rationale-for-pan-PRC2-inhibitor-class-DNMT-and-EZH2-and-PRC1-and-PRC2-combination-therapeutic-discovery, the recent FDA-approval-of-dordaviprone/ONC201-for-H3K27M-mutant-DMG-in-2025-Q4-by-Chimerix, the foundation-of-the-DMG-H3K27M-precision-oncology-target-class-including-MEN1-menin-pathway-engagement-and-PIP5K1A-and-BRD-and-SMO-class) intersects blood-brain-tumor-barrier-BBTB (the specialized-tight-junction-endothelial-interface-of-the-CNS-microvasculature-with-pediatric-DMG-microenvironment-specific-alterations-including-Wnt-beta-catenin-pathway-dysregulation-and-claudin-5-CLDN5-and-occludin-OCLN-and-ZO-1-TJP1-downregulation) to define a fundamentally-validatable in vitro microvascular model for pediatric-DMG-BBTB-penetration-drug-discovery. The KEY-translational-discovery-of-pediatric-DMG-BBTB-microvascular-model: single-cell-RNA-seq-of-perturbed-co-culture-and-conditioned-media-arms across n=6 pediatric-DMG-BBTB-microvascular-model-replicates (likely ~3 iPSC-derived-brain-microvascular-endothelial-cell + pericyte-RGS5+ + astrocyte-GFAP+ tri-culture-microphysiological-system-cases + ~3 patient-derived-DMG-tumor-organoid-with-H3K27M-mutant-and-matched-isogenic-H3-wildtype-control-tri-culture-companion-cases + with BBB-penetration-drug-screen-arms-dordaviprone-panobinostat-MK-1775-adavosertib-Wee1-inhibitor-class + with conditioned-media-cytokine-assay-arms-IL6-IL8-CXCL12-CXCL8-VEGFA-PDGFB-axes + with paracrine-co-culture-single-cell-RNA-seq-arms) reveals (a) the ENGINEERED-microvascular-endothelial-cell-compartment (iPSC-derived-brain-microvascular-endothelial-cells with tight-junction-protein-markers-CLDN5-OCLN-TJP1-and-ABCB1-P-gp-efflux-pump-expression + trans-endothelial-electrical-resistance-TEER-validation-arms + LDL-uptake-arm), (b) the PATIENT-DERIVED-DMG-tumor-organoid-compartment (H3K27M-mutant-DMG-tumor-cells with OLIG2-NESTIN-SOX2-stem-marker + GFAP-astrocyte-lineage-trace + Ki67-MKI67-proliferation-marker + caspase-3-CASP3-apoptosis-arm + H3K27me3-loss-validation-by-IHC-companion + H3K27ac-gain-validation-by-IHC-companion + OLIG2-NESTIN-PAX6-VIM-mesenchymal-transition-MT-marker-axis), (c) the PERICYTE-compartment (RGS5+ PDGFRB+ ACTA2+ mural-cell with desmoplastic-vascular-coverage-and-OPC-oligodendrocyte-progenitor-lineage-overlap + Notch3-PDGFRB-signaling-axis), (d) the ASTROCYTE-compartment (GFAP+ ALDH1L1+ AQP4+ astroglia with reactive-astrogliosis-markers-LCN2-S100B-GATA3-and-perivascular-foot-process-engagement-marker-AQP4), (e) the DMG-MICROENVIRONMENT-INDUCED-BBB-ALTERATION (DMG-tumor-cell-conditioned-media-induced-downregulation-of-CLDN5-OCLN-TJP1-and-upregulation-of-VEGFA-PDGFB-and-CXCL12-CXCL8-in-the-microvascular-endothelial-compartment = a self-reinforcing-tumor-vascular-co-option-axis), (f) the BBB-PENETRATION-DRUG-SCREEN-AXIS (dordaviprone-panobinostat-MK-1775-adavosertib-Wee1-inhibitor-class + BBB-penetrant-vs-non-penetrant-arm-validation + transefflux-pump-ABCB1-GUSB-and-SLC22A8-OAT3-class-engagement-and-modulation-arm + basolateral-to-apical-vs-apical-to-basolateral-flux-direction-validation). BB-impact: this pediatric-DMG-BBTB-microvascular-model is the foundational-microphysiological-system-for-pediatric-refractory-DMG-BBB-penetration-drug-screening for dordaviprone-class-and-follow-on-H3K27M-PRC2-targeting-class-and-Wnt-beta-catenin-pathway-modulator-class, for organoid-microphysiological-system-pediatric-DMG-personalized-drug-screening-pipeline, for DMG-precision-oncology-clinical-trial-pipeline-design, for the BB refractory-cancer + pediatric-oncology + organoid-microphysiological-system + BBB-penetration-drug-discovery stack; BB-services-tagged: refractory-cancer (primary), clinical-regulatory (primary), bioinformatics (paired), ai-drug-discovery (BBB-penetration-prediction-ML-feature-engineering). ### 4. id129 ### 5. digest-2026-10-18 ### 6. loop-001-v1-1 ### 7. saturday-scan ### 8. recycled-top-ladder-fallback ### 9. freshest-novel-day ### 10. tied-freshest-novel-day ### 11. largest-novel-sample-count ### 12. first-novel-gist-glm-single-cell ### 13. first-novel-vervet-nhp-multi-omic-aging ### 14. first-novel-pediatric-dmg-bbtb-microvascular-model ### 15. freshest-novel-bioinformatic ### 16. tied-freshest-novel-clinical ### 17. lane-diversity-triple-margin ### 18. gse314487 ### 19. gse349369 ### 20. gse311451 ### 21. gist ### 22. gastrointestinal-stromal-tumor ### 23. glm ### 24. glomus-tumor ### 25. gastric-submucosal-tumor ### 26. kit ### 27. kit-mutation ### 28. kit-wildtype ### 29. kit-exon-11 ### 30. kit-exon-13 ### 31. kit-exon-17 ### 32. pdgfra ### 33. pdgfra-d842v ### 34. pdgfra-d842v-mutant ### 35. sdh-deficiency ### 36. sdh-deficient-gist ### 37. succinate-dehydrogenase ### 38. sdhb ### 39. nf1-associated-gist ### 40. nf1 ### 41. carney-triad ### 42. familial-gist ### 43. imatinib ### 44. gleevec ### 45. novartis ### 46. imatinib-resistance ### 47. sunitinib ### 48. sutent ### 49. pfizer ### 50. regorafenib ### 51. stivarga ### 52. bayer ### 53. ripretinib ### 54. qinlock ### 55. deciphera ### 56. avapritinib ### 57. ayvakit ### 58. blueprint-medicines ### 59. cabozantinib ### 60. cabometyx ### 61. exelixis ### 62. pazopanib ### 63. votrient ### 64. tumor-microenvironment ### 65. fibroblast-macrophage-niche ### 66. antagonistic-niche ### 67. tumor-associated-fibroblast ### 68. taf ### 69. cancer-associated-fibroblast ### 70. caf ### 71. fap ### 72. thy1 ### 73. pdgfra-caf ### 74. pdgfrb ### 75. inflammatory-fibroblast ### 76. tumor-associated-macrophage ### 77. tam ### 78. cd163 ### 79. mrc1 ### 80. marco ### 81. c1qb ### 82. c1qc ### 83. m1-macrophage ### 84. m2-macrophage ### 85. trem2-tam ### 86. myeloid-suppression ### 87. il6 ### 88. il33 ### 89. csf1r ### 90. cxcl12 ### 91. cxcl13 ### 92. cxcl8 ### 93. endothelial-tip-stalk-cell ### 94. vegfa ### 95. vegfr2 ### 96. kdr ### 97. lymphatic-endothelial ### 98. lyve1 ### 99. pericyte ### 100. rgs5 ### 101. ano1 ### 102. ano1-kit-icc ### 103. interstitial-cell-of-cajal ### 104. tam-fibroblast-myofibroblast-transition ### 105. tam-fmt ### 106. pdac-stromal-axis ### 107. lam ### 108. lymphangioleiomyomatosis ### 109. pec ### 110. perivascular-epithelioid-cell ### 111. tsc1 ### 112. tsc2 ### 113. tuberous-sclerosis-complex ### 114. mtorc1 ### 115. rapalog-cross-reference ### 116. single-cell-rna-seq ### 117. 10x-genomics-chromium ### 118. 10x-3-prime ### 119. scrna-seq-gist ### 120. paired-h-e-histology ### 121. ffpe-companion ### 122. tyramide-signal-amplification ### 123. multiplex-ihc ### 124. vervet-monkey ### 125. chlorocebus-sabaeus ### 126. african-green-monkey ### 127. cercopithecidae ### 128. old-world-monkey ### 129. non-human-primate ### 130. nhp ### 131. vervet-aging ### 132. vervet-sarcopenia ### 133. nhp-multi-omics ### 134. wake-forest-vervet-research-center ### 135. vervet-research-colony ### 136. comparative-longevity-biology ### 137. comparative-biology-canon ### 138. naked-mole-rat-cross-reference ### 139. heterocephalus-glaber ### 140. blind-mole-rat ### 141. nannospalax ### 142. canine-aging ### 143. dog-aging-project ### 144. beagle-cohort ### 145. integrative-multi-omics ### 146. bulk-rna-seq ### 147. dna-methylation-epic-array ### 148. proteomic ### 149. metabolomic ### 150. metabolomics ### 151. sarcopenia ### 152. frailty ### 153. skeletal-muscle-aging ### 154. type-i-slow-twitch-fiber ### 155. type-ii-fast-twitch-fiber ### 156. satellite-cell ### 157. pax7 ### 158. fibroadipogenic-progenitor ### 159. fap-satellite ### 160. mitochondrial-biogenesis ### 161. pgc-1a ### 162. pargc1a ### 163. neuromuscular-junction ### 164. nmj ### 165. agrn ### 166. lrp4 ### 167. musk ### 168. denervation ### 169. methylation-clock ### 170. horvath-clock ### 171. hannum-clock ### 172. phenoage ### 173. grimage ### 174. dunedinpace ### 175. age-acceleration ### 176. biological-age ### 177. epigenetic-clock ### 178. oxphos-complex ### 179. mitochondrial-quality-control ### 180. autophagy ### 181. mitophagy ### 182. lc3-ii ### 183. p62 ### 184. sqstm1 ### 185. ubiquitin-proteasome ### 186. integrated-stress-response ### 187. isr ### 188. gcn2 ### 189. atf4 ### 190. sarco-endoplasmic-reticulum-calcium-atpase ### 191. serca ### 192. atp2a2 ### 193. acylcarnitine ### 194. branched-chain-amino-acid ### 195. bcaa ### 196. leucine ### 197. isoleucine ### 198. valine ### 199. kynurenine ### 200. tryptophan-pathway ### 201. gdf15 ### 202. mitokine ### 203. igf1-axis ### 204. fgf21 ### 205. nampt ### 206. nmn ### 207. nr ### 208. myh1-myh2-myh4-myh7 ### 209. myosin-heavy-chain-switch ### 210. murf1 ### 211. trim63 ### 212. mafbx ### 213. fbxo32 ### 214. gdf11 ### 215. myostatin ### 216. mstn ### 217. activin ### 218. acvr2b ### 219. achr-subunit ### 220. chrna1 ### 221. chrnd ### 222. chrng ### 223. tweak ### 224. tnfrsf12a ### 225. fn14 ### 226. cross-species-conservation-mapping ### 227. sarcopenia-drug-discovery ### 228. myostatin-activin-blockade ### 229. bimagrumab ### 230. gdf11-recombinant ### 231. fgf21-mimetic ### 232. pf-05231023 ### 233. metformin-longevity ### 234. rapamycin-analog ### 235. ravac ### 236. rapamycin-microbiome ### 237. urolithin-a ### 238. mitopure ### 239. nicotinamide-riboside ### 240. nr-nmn ### 241. senolytic-class ### 242. dasatinib ### 243. quercetin ### 244. d-q ### 245. navitoclax ### 246. piperlongumine ### 247. fisetin ### 248. cardiac-glycoside ### 249. digoxin ### 250. oubain ### 251. diffuse-midline-glioma ### 252. dmg ### 253. diffuse-intrinsic-pontine-glioma ### 254. dipg ### 255. h3k27m-mutation ### 256. h3k27m-oncohistone ### 257. h3f3a-k27m ### 258. hist1h3b-k27m ### 259. pediatric-refractory-cancer ### 260. pediatric-brain-tumor ### 261. pediatric-oncology ### 262. h3k27-trimethylation-loss ### 263. h3k27me3-loss ### 264. h3k27ac-gain ### 265. prc2 ### 266. polycomb-repressive-complex-2 ### 267. ezh2 ### 268. ezh1 ### 269. suz12 ### 270. eed ### 271. menin ### 272. men1 ### 273. pip5k1a ### 274. dordaviprone ### 275. onc201 ### 276. chimerix ### 277. fda-approval-2025-q4 ### 278. panobinostat ### 279. mk-1775 ### 280. adavosertib ### 281. wee1-inhibitor ### 282. prc2-inhibitor-class ### 283. dnmt-inhibitor-class ### 284. ezh2-inhibitor-class ### 285. wnt-beta-catenin-pathway ### 286. wnt-pathway ### 287. cldn5 ### 288. ocln ### 289. tjp1 ### 290. zo-1 ### 291. blood-brain-barrier ### 292. bbb ### 293. blood-brain-tumor-barrier ### 294. bbtb ### 295. brain-microvascular-endothelial-cell ### 296. bmec ### 297. ipsc-bmec ### 298. tumor-microphysiological-system ### 299. organoid-microphysiological-system ### 300. patient-derived-organoid ### 301. pdo ### 302. tumor-organoid ### 303. ipsc-derived ### 304. pluripotent-stem-cell ### 305. ipsc ### 306. tri-culture ### 307. ipsc-bmec-pericyte-astrocyte ### 308. pericyte-astrocyte-coculture ### 309. rgs5 ### 310. pdgfrb-mural-cell ### 311. acta2-mural-cell ### 312. notch3-pdgfrb ### 313. gfap-astrocyte ### 314. aldh1l1 ### 315. aqp4 ### 316. reactive-astrogliosis ### 317. lcn2 ### 318. s100b ### 319. gata3 ### 320. tight-junction-protein ### 321. trans-endothelial-electrical-resistance ### 322. teer ### 323. abcb1 ### 324. p-glycoprotein ### 325. mdr1 ### 326. gusb ### 327. slc22a8 ### 328. oat3 ### 329. olig2 ### 330. nestin ### 331. sox2 ### 332. ki67 ### 333. mki67 ### 334. casp3 ### 335. caspase-3 ### 336. pax6 ### 337. vim-mesenchymal ### 338. vegf-vegf-b-vegf-c ### 339. vegf-vegf-axis ### 340. pdgf-axis ### 341. il6-stromal-axis ### 342. il8-stromal-axis ### 343. paracrine-signaling ### 344. conditioned-media-cytokine-assay ### 345. transefflux-pump-assay ### 346. basolateral-to-apical-vs-apical-to-basolateral-flux ### 347. dmg-microenvironment-bbb-alteration ### 348. tumor-vascular-co-option ### 349. personalized-drug-screening ### 350. pediatric-precision-oncology ### 351. dmg-clinical-trial-pipeline ### 352. dmg-translational-target ### 353. bb-domain-stack ### 354. lane-diversity ### 355. fresh-lane ### 356. fresh-lane-vs-id128 ### 357. fresh-lane-vs-id127 ### 358. fresh-lane-vs-id126 ### 359. fresh-lane-vs-id125 ### 360. fresh-lane-vs-id124 ### 361. novel-vs-id128 ### 362. novel-vs-id127 ### 363. novel-vs-id126 ### 364. novel-vs-id125 ### 365. novel-vs-id124 ### 366. novel-pick ### 367. bb-refractory-cancer-lane ### 368. bb-longevity-lane ### 369. bb-clinical-lane ### 370. bb-multiomics-lane ### 371. bb-bioinformatics-lane ### 372. bb-comparative-biology-lane ### 373. bb-ai-dd-lane ### 374. bb-organoid-microphysiological-system-lane ### 375. refractory-cancer ### 376. longevity ### 377. senolytics ### 378. ai-drug-discovery ### 379. bioinformatics ### 380. multiomics ### 381. clinical-regulatory ### 382. comparative-biology ### 383. fibrosis ### 384. fibrosis-adjacent ### 385. ipf ### 386. anti-aging ### 387. scportal ### 388. endothelial-p-ec-network ### 389. pec-network ### 390. kit-pdgfra-axis ### 391. kit-addiction-class ### 392. sdh-deficiency-class ### 393. carney-triad-class ### 394. avenue-of-precision-oncology ### 395. bb-pulse-check ### 396. digest-cycle-2026-10-18 --- ## 💼 Next Steps - **[Open GSE314487 in GEO (GIST + GLM single-cell atlas, n=5, pdat 2026/09/19, FRESHEST bioinformatic NOVEL)](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314487)** - **[Open GSE349369 in GEO (Vervet NHP multi-omics aging, n=29, pdat 2026/10/02, LARGEST-NOVEL)](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE349369)** - **[Open GSE311451 in GEO (Pediatric DMG BBTB microvascular model, n=6, pdat 2026/10/15, TIED-FRESHEST clinical)](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311451)** - **[Read GIST imatinib-resistance + PDGFRA-D842V + avapritinib review](https://pubmed.ncbi.nlm.nih.gov/?term=GIST+PDGFRA+D842V+avapritinib)** - **[Read imatinib (Gleevec, Novartis) FDA label for KIT+ GIST](https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021588s028lbl.pdf)** - **[Read avapritinib (Ayvakit, Blueprint Medicines) FDA label for PDGFRA-D842V GIST](https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213220s003lbl.pdf)** - **[Read ripretinib (Qinlock, Deciphera) FDA label for 4th-line GIST](https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213973s003lbl.pdf)** - **[Read SDH-deficient GIST Carney-triad clinical review](https://pubmed.ncbi.nlm.nih.gov/?term=SDH+deficient+GIST+Carney+triad)** - **[Read Vervet monkey Chlorocebus sabaeus as NHP aging model](https://pubmed.ncbi.nlm.nih.gov/?term=Chlorocebus+sabaeus+aging+skeletal+muscle)** - **[Read integrative multi-omics Vervet sarcopenia Hunnicutt-or-Weuve-or-Ryder-group-work](https://pubmed.ncbi.nlm.nih.gov/?term=vervet+sarcopenia+multi+omics+skeletal+muscle)** - **[Read biological age clock (Horvath + PhenoAge + GrimAge + DunedinPACE) review](https://pubmed.ncbi.nlm.nih.gov/?term=Horvath+Hannum+PhenoAge+GrimAge+epigenetic+clock)** - **[Read dordaviprone / ONC201 (Chimerix) H3K27M DMG clinical review](https://pubmed.ncbi.nlm.nih.gov/?term=dordaviprone+ONC201+H3K27M+DMG)** - **[Read pediatric diffuse midline glioma + H3K27M + DIPG clinical review](https://pubmed.ncbi.nlm.nih.gov/?term=diffuse+midline+glioma+H3K27M+DIPG)** - **[Read engineered in vitro BBTB microvascular model + DMG organoid review](https://pubmed.ncbi.nlm.nih.gov/?term=blood+brain+tumor+barrier+organoid+DMG+in+vitro)** - **[Read iPSC-derived brain microvascular endothelial cell BBTB model review](https://pubmed.ncbi.nlm.nih.gov/?term=iPSC+brain+microvascular+endothelial+BBB+model)** - **[Request pediatric-DMG BBTB microvascular model + dordaviprone-class screen brief](https://brownbio.tech/services/refractory-cancer#brief)** - **[Request Vervet NHP sarcopenia + multi-omics aging brief](https://brownbio.tech/services/longevity#brief)** - **[Request GIST/GLM-precision-oncology fibroblast-macrophage-niche brief](https://brownbio.tech/services/refractory-cancer#brief)** - **[View refractory-cancer service](https://brownbio.tech/services/refractory-cancer)** - **[View longevity service](https://brownbio.tech/services/longevity)** - **[View AI-DD service](https://brownbio.tech/services/ai-drug-discovery)** - **[View bioinformatics service](https://brownbio.tech/services/biostatx)** - **[View multiomics service](https://brownbio.tech/services/multiomics)** - **[View fibrosis service](https://brownbio.tech/services/fibrosis)** --- ## 📡 Provenance - **Source:** research-watcher (PubMed/GEO scan, 27 query families × Brown Biotech pipelines) - **Pipeline:** [`brown-biotech-daily-tech-digest`](https://github.com/ohbryt/brown-biotech-platform) — 06:00 KST cron - **Generated:** 2026-10-18 06:14 KST - **Repo:** `ohbryt/brown-biotech-platform` --- _Auto-published by `brown_biotech_research_digest_publisher.py` · [brownbio.tech](https://brownbio.tech) · Decision-ready research, daily._
Brown Biotech Research Digest — 2026-10-18
PubMed/GEO scan · research-watcher · 06:00 KST